Forte Biosciences Inc.
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 34 institutions reported holding Forte Biosciences Inc. in their 13F filings, up 1 from Q1 2024. 3 opened new positions and 3 sold out. The largest holders were Tybourne Capital Management (hk) Ltd. ($1.9M), Perceptive Advisors LLC ($1.8M) and BVF Inc. ($1.6M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Forte Biosciences Inc.
- CUSIP
- 34962G109
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $19K |
| Exits | 3 | $25K |
All 13F filers, Q1 2024 → Q2 2024: 70,142 shares bought and 72,298 shares sold, net −2,156 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 34 holders
| Tybourne Capital Management (hk) Ltd. | 0.40% | No change | 3,624,548 | $1.9M |
| Perceptive Advisors LLC | 0.04% | No change | 3,265,359 | $1.8M |
| BVF Inc. | 0.04% | No change | 2,982,105 | $1.6M |
| Cable Car Capital, LP | 1.20% | No change | 2,031,987 | $1.1M |
| Fred Alger Management, LLC | 0.00% | No change | 1,838,965 | $988K |
| Farallon Capital Management, L.L.C. | 0.01% | No change | 1,810,455 | $972K |
| BML Capital Management, LLC | 0.69% | No change | 1,761,702 | $946K |
| Vanguard Group Inc. | 0.00% | No change | 665,230 | $357K |
| Geode Capital Management, LLC | 0.00% | Add +0.8% | 346,292 | $186K |
| BlackRock Inc. | 0.00% | No change | 174,858 | $94K |
| ADAR1 Capital Management, LLC | 0.02% | Reduce -6.6% | 159,258 | $86K |
| Renaissance Technologies | 0.00% | Add +1.0% | 133,400 | $72K |
| Two Sigma Investments, LP | 0.00% | Reduce -0.1% | 40,811 | $22K |
| State Street Corp. | 0.00% | Reduce -9.8% | 37,564 | $20K |
| Susquehanna International Group, LLP | 0.00% | New | 34,344 | $18K |
| Sanctuary Advisors, LLC | 0.00% | — | 22,014 | $16K |
| Northern Trust Corp. | 0.00% | Reduce -0.3% | 26,817 | $14K |
| UBS Group AG | 0.00% | Add +73566.7% | 24,310 | $13K |
| Goldman Sachs Group Inc. | 0.00% | Add +0.0% | 20,776 | $11K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +35.7% | 15,798 | $8K |
| Group One Trading LLC | 0.00% | Reduce -3.5% | 14,017 | $8K |
| Aries Wealth Management | 0.00% | No change | 13,000 | $7K |
| HSBC Holdings PLC | 0.00% | No change | 10,745 | $6K |
| Citadel Advisors | 0.00% | Reduce -71.3% | 8,097 | $4K |
| Morgan Stanley | 0.00% | Add +282.7% | 3,804 | $2K |
| Osaic Holdings, Inc. | 0.00% | No change | 1,080 | $582 |
| Russell Investments Group, Ltd. | 0.00% | No change | 453 | $243 |
| Bank of America Corp. | 0.00% | New | 265 | $142 |
| Loring Wolcott & Coolidge Fiduciary Advisors LLP | 0.00% | No change | 193 | $112 |
| FMR LLC | 0.00% | New | 128 | $69 |
| REAP Financial Group, LLC | 0.00% | No change | 97 | $52 |
| JPMorgan Chase & Co. | 0.00% | No change | 17 | $9 |
| Qube Research & Technologies Ltd | 0.00% | No change | 3 | $2 |
| Royal Bank of Canada | 0.00% | No change | 137 | $0 |
"% of holder's portfolio" is FORTE BIOSCIENCES INC's weight in each manager's 13F, not the share of Forte Biosciences Inc. the manager owns.